Effects of Posture Correction Band on Pulmonary Function and Chest Expansion in Asymptomatic Population with Forward Head Posture

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191117045462N4

Enrollment

Registered

2021-08-16

Start date

2021-06-01

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Forward Head Posture: Forward head posture (FHP) defines as an increased curvature of the cervical vertebrae due to the extension of head and upper cervical vertebrae (Cl-C3) and the flexion of the lower cervical vertebrae (C4-C7), resulting in the forward head posture. Condition 2: Neck pain is associated with Forward head posture. Abnormal posture Cervicalgia

Interventions

Intervention 1: Intervention group: G1 group will be the treatment group who wore posture correction belt for 2 hours and their Pulmonary Function Test (PFT) and chest expansion will be measured after

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Had a cranio-vertebral angle less than 50° Had some neck pain and disability, less than 5 as measured by Urdu version of the neck disability index (NDI).

Exclusion criteria

Exclusion criteria: Had a history of spinal or chest surgery Had a history of smoking Had an acute or chronic neuromusculoskeletal pain Had severe obesity (body mass index > 40), diabetes, or malignant tumors Had clinical abnormalities or severe comorbidities.

Design outcomes

Primary

Measure	Time frame
Vital Capacity (VC). Timepoint: Pre and Post treatment (2 hours). Method of measurement: Pulmonary function test: spirometer.;Forced Vital Capacity (FVC). Timepoint: Pre and Post treatment (2 hours). Method of measurement: Pulmonary function test: spirometer.;Peak Expiratory Flow (PEF). Timepoint: Pre and Post Treatment (2 hours). Method of measurement: Pulmonary function test: spirometer.;Forced Expiratory Volume at one second (FEV1). Timepoint: Pre and Post Treatment (2 hours). Method of measurement: Pulmonary function test: spirometer.;Chest Expansion. Timepoint: Pre and Post Treatment (2 hours). Method of measurement: Measuring Tape.	—

Measure

Time frame

Vital Capacity (VC). Timepoint: Pre and Post treatment (2 hours). Method of measurement: Pulmonary function test: spirometer.;Forced Vital Capacity (FVC). Timepoint: Pre and Post treatment (2 hours). Method of measurement: Pulmonary function test: spirometer.;Peak Expiratory Flow (PEF). Timepoint: Pre and Post Treatment (2 hours). Method of measurement: Pulmonary function test: spirometer.;Forced Expiratory Volume at one second (FEV1). Timepoint: Pre and Post Treatment (2 hours). Method of measurement: Pulmonary function test: spirometer.;Chest Expansion. Timepoint: Pre and Post Treatment (2 hours). Method of measurement: Measuring Tape.

—

Countries

Pakistan

Contacts

Public ContactWajeeha Zia

Riphah College of Rehabilitation and Allied Health Sciences, Lahore

wajeeha_z@yahoo.com+92 42 111 747 424

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026